Taoyuan County, Taiwan

Mao-Chi Weng

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Taoyuan County, TW (2017 - 2018)
  • Taoyuan, TW (2018 - 2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Mao-Chi Weng

Introduction

Mao-Chi Weng, an accomplished inventor based in Taoyuan County, Taiwan, holds a remarkable portfolio with four patents to his name. His groundbreaking work primarily focuses on the field of biomedical imaging and therapeutic applications, particularly in enhancing the diagnosis and treatment of neurological disorders.

Latest Patents

Among Mao-Chi Weng's notable inventions is the patent for a hydroxamic acid type contrast agent containing a radioisotope fluoride. This innovative agent selectively inhibits histone deacetylase (HDAC) subtypes 8/6/3 and is specifically designed to target the focus of spinocerebellar ataxia, a condition characterized by the over-activation of HDAC. By labeling this contrast agent with the radioisotope fluorine-18, it facilitates the effective detection of spinocerebellar ataxia through positron emission tomography (PET) imaging. This invention holds tremendous potential for the early diagnosis and assessment of therapeutic responses in patients.

Additionally, Weng developed a radiolabeled active targeting pharmaceutical composition, which combines a bioconjugate with a radionuclide. This composition includes biomolecules that target cell membrane receptors and has been utilized to evaluate thermal adjuvant therapy for tumors. Such advancements provide critical insights into the optimal timings for treatments involving radiofrequency or laser-induced therapies.

Career Highlights

Mao-Chi Weng has significantly contributed to his field through his work at the Institute of Nuclear Energy Research under the Atomic Energy Council, Executive Yuan. His time at one of Taiwan's leading research institutions allowed him to focus on applying nuclear technology in innovative ways to improve healthcare solutions.

Collaborations

In his journey as an inventor, Weng has collaborated with esteemed colleagues, including Chien-Chung Hsia and Hsin-Ell Wang. Their joint efforts have further pushed the boundaries of research in nuclear medicine and therapeutic development, emphasizing teamwork in scientific advancements.

Conclusion

Mao-Chi Weng's contributions to the fields of biomedical imaging and therapeutic compositions illustrate the vital role of innovation in healthcare. His patents represent significant strides in early diagnosis and treatment evaluation, showcasing how targeted solutions can enhance patient care. As he continues his work, the impact of his inventions is poised to benefit many in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…